Steven Galson

Steven K.
Galson is currently an Independent Director at BioCryst Pharmaceuticals, Inc. since 2021 and an Independent Director at Elephas Biosciences Corp.
since 2022.
Formerly, Dr. Galson was an Independent Director at Vanda Pharmaceuticals, Inc. from 2011 to 2015, Director at The National Board of Medical Examiners, Inc., Deputy Director at the Center for Drug Evaluation & Research, Director of the Science Coordination & Policy Office at the United States Environmental Protection Agency, Independent Director at InSilico Medicine Hong Kong Ltd., Director of the Center for Drug Evaluation & Research at the US Food & Drug Administration from 2001 to 2007, Senior Vice President of Global Regulatory Affairs & Safety at Amgen, Inc. from 2014 to 2021, Senior Vice President of Civilian Health Operations at Leidos, Inc. in 2010, Chief Health Scientist at Science Applications International Corp., Chief Medical Officer at the Environmental Protection Agency, Chief Medical Officer at the US Department of Energy (District of Columbia), and Chief Operating Officer at ProQR Therapeutics NV from 2021 to 2022.
Education includes undergraduate studies at Stony Brook University, a doctorate from Icahn School of Medicine at Mount Sinai in 1983, and graduate studies at Harvard T.H.
Chan School of Public Health completed in 1990.